Parvalbumin expression changes with retinal ganglion cell degeneration

Area of Science:

• Neuroscience
• Ophthalmology
• Molecular Biology

Background:

• Glaucoma is a leading cause of irreversible blindness globally.
• Vision loss in glaucoma stems from progressive degeneration of retinal ganglion cells (RGCs) and their axons.
• Identifying objective molecular markers is crucial for glaucoma diagnosis and understanding its pathophysiology.

Purpose of the Study:

• To investigate the expression of Parvalbumin (PVALB) in relation to RGC and optic nerve degeneration in glaucoma models.
• To assess the potential of PVALB as a molecular marker for glaucoma research.

Main Methods:

• Utilized DBA/2J (glaucoma model) and C57BL6/J (optic nerve crush model) mice.
• Assessed PVALB expression using gene expression microarray, qRT-PCR, Western blot, and immunohistochemistry.

Main Results:

• PVALB expression was downregulated in DBA/2J mice as glaucoma progressed and RGCs were lost.
• Both mRNA and protein levels of PVALB were significantly reduced in the retinas and optic nerves of glaucomatous DBA/2J mice and after optic nerve crush.
• Immunohistochemistry revealed fewer PVALB-positive cells in the retina and altered staining in the optic nerve following injury.

Conclusions:

• PVALB is expressed in RGCs and their axons in healthy mice.
• PVALB expression decreases with RGC degeneration in glaucoma and after optic nerve injury.
• PVALB is a reliable molecular marker for studying retinal and optic nerve degeneration in glaucoma.